Terapia Intensiva
Estudo randomizado | Estudo preliminar sugere que a neostigmina pode melhorar a hipertensão intra-abdominal e a defecação em pacientes com pancreatite aguda.
8 Mar, 2022 | 16:43hRevisão sistemática | Distribuição dos subtipos de delirium motor na UTI.
8 Mar, 2022 | 16:42h[Preprint] Estudo RECOVERY mostra que baricitinibe reduz mortes em pacientes internados com COVID-19.
8 Mar, 2022 | 16:22hComunicado de imprensa: RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19 – University of Oxford
Comentários:
Arthritis drug reduces mortality in severe COVID-19, huge clinical trial finds – Science
Another life-saving Covid drug identified – BBC
Conteúdos relacionados:
WHO recommends two new drugs (Baricitinib and Sotrovimab) to treat COVID-19.
RCT: Baricitinib reduced mortality in hospitalized adults with COVID-19.
Randomized trial: Baricitinib plus remdesivir reduce recovery time in patients with COVID-19
Comentário do autor no Twitter (fio – clique para saber mais)
RECOVERY pre-print: Baricitinib
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis https://t.co/g0cNjaBzEL
— Martin Landray (@MartinLandray) March 3, 2022
Revisão | Estratégias terapêuticas para Pseudomonas aeruginosa multirresistente.
8 Mar, 2022 | 15:03hConteúdos relacionados:
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
Acinetobacter baumannii resistente a carbapeném: colonização, infecção e opções atuais de tratamento.
8 Mar, 2022 | 15:02hConteúdos relacionados:
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
Estudo de coorte | Troponina I de alta sensibilidade após cirurgia cardíaca e mortalidade em 30 dias.
3 Mar, 2022 | 16:51hHigh-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
NEJM study evaluates levels of HS Troponin after cardiac surgery and risk of death – MedicalResearch
Conteúdo relacionado: Retrospective cohort: Serial high-sensitivity cardiac troponin I after coronary artery bypass grafting may add prognostic information for post-operative decision-making.
Comentário no Twitter
The levels of high-sensitivity troponin I associated with an increased risk of death within 30 days after cardiac surgery are higher than levels currently used to define clinically important periprocedural myocardial injury. https://t.co/bnwPzQmh1h pic.twitter.com/pdmx23jPdz
— NEJM (@NEJM) March 2, 2022
Estudo randomizado | Aspirina e heparina não fracionada aumentam o risco de hemorragia intracraniana sintomática em pacientes submetidos a tratamento endovascular de AVC isquêmico.
3 Mar, 2022 | 16:50hSafety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial – The Lancet (link para o resumo – $ para o texto completo)
M-A | Uso de tocilizumabe e sarilumabe isoladamente ou em combinação com corticosteroides para Covid-19.
3 Mar, 2022 | 16:44hEditorial: Treatment of severe covid-19 with interleukin 6 receptor inhibition – BMJ Medicine
Estudo relacionado (publicado recentemente): Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis – JAMA Network Open
Estudo randomizado | Efeito da otimização de doses com base no monitoramento medicamentoso de piperacilina/tazobactam na disfunção de órgão relacionada a sepse em pacientes sépticos.
3 Mar, 2022 | 16:31h
Comentário no Twitter
Therapeutic drug monitoring‑guided pip/tazo infusion vs fixed dose in #sepsis, TARGET RCT:
🧪no significant difference in mean SOFA
⬇️28-day mortality + ⬆️ clinical/microbiological cure if TDM (no statistical significance)
Results https://t.co/cLS1OQ173I
⬇️Below visual abstract pic.twitter.com/jRjzfNLj1T— Intensive Care Medicine (@yourICM) March 1, 2022
Estudo observacional sugere que a norepinefrina é uma opção melhor do que a epinefrina em pacientes com parada cardíaca e choque pós-ressuscitação.
3 Mar, 2022 | 16:29hEpinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock – Intensive Care Medicine (link para o resumo – $ para o texto completo)
Conteúdo relacionado: Randomized Trial: Epinephrine vs Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction
Noradrenaline better vs adrenaline in cardiac arrest pts with post #resus shock?
💉766 pts, 5 🏥
🏥 noradrenaline better survival/neuro-outcome: all-cause & cardiovascular mortality significantly ⬆️ with epinephrine
🖇️ Results #FOAMcc https://t.co/ihuEPg8sGq
⬇️ Visual Abstract pic.twitter.com/aakmkpPxXf— Intensive Care Medicine (@yourICM) February 24, 2022


